^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Chronic Myeloid Leukemia
    Drug:busulfan (Alkylating agent)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    FDA
    Published date:
    12/24/2003
    Excerpt:
    MYLERAN (busulfan) is indicated for the palliative treatment of chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia.